A new study shows how different pharmaceutical drugs hit either the ‘on’ or ‘off’ switch of a signaling protein linked to asthma, obesity and type 2 diabetes.
A new study shows how different pharmaceutical drugs hit either the ‘on’ or ‘off’ switch of a signaling protein linked to asthma, obesity and type 2 diabetes.